Home › Funds › First Eagle Investment Management › IRWD
First Eagle Investment Management position in IRWD
IRONWOOD PHARMACEUTICALS INC · Health Care
Latest position (Q2 2024)1.10M sh
Reported value held$7.20M
Portfolio Weight0.02%
First reportedQ3 2022
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2022 | 255.50K | $2.65M | New |
| Q4 2022 | 340.53K | $4.22M | Add |
| Q1 2023 | 491.36K | $5.17M | Add |
| Q2 2023 | 589.89K | $6.28M | Add |
| Q3 2023 | 816.59K | $7.86M | Add |
| Q4 2023 | 907.23K | $10.38M | Add |
| Q1 2024 | 1.00M | $8.73M | Add |
| Q2 2024 | 1.10M | $7.20M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding IRWD
- BlackRock Inc 17.79M sh · $74.89M · Q2 2026
- Vanguard Group 15.96M sh · $53.78M · Q4 2025
- Bank of America Corp 8.68M sh · $36.56M · Q2 2026
- Renaissance Technologies 7.99M sh · $33.65M · Q2 2026
- AQR Capital Management 6.47M sh · $27.22M · Q2 2026
- Geode Capital Management 4.83M sh · $20.35M · Q2 2026
- Two Sigma Investments 4.56M sh · $19.18M · Q2 2026
- Marshall Wace 4.29M sh · $18.06M · Q2 2026
- Goldman Sachs Group 3.31M sh · $13.95M · Q2 2026
- Charles Schwab Investment Management 3.30M sh · $13.90M · Q2 2026
- Arrowstreet Capital 3.02M sh · $12.70M · Q2 2026
- Morgan Stanley 1.86M sh · $7.83M · Q2 2026